首页 > 最新文献

Current Opinion in Pulmonary Medicine最新文献

英文 中文
Mild airways obstruction: spirometric diagnostic pitfalls and solutions. 轻度气道阻塞:肺活量诊断误区与解决方案。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-03-01 Epub Date: 2023-10-19 DOI: 10.1097/MCP.0000000000001023
Nawaf M Alotaibi, Rachel L Eddy, Don D Sin

Purpose of review: Spirometry is a validated tool in the diagnosis of obstructive airways disease. However, it may be insufficiently sensitive in detecting airflow limitation in the small airways. This review highlights common clinical scenarios wherein airflow limitation may be missed or overlooked.

Recent findings: This article covers recent literature on the interpretation of lung function test, focusing on detection of mild obstructive airways disease. It also sheds light on the contextual difficulties of defining mild airflow limitation on spirometry.

Summary: We highlight the consensus definition of mild obstructive airways disease and emphasize that this definition does not necessarily mean mild in certain disease-specific contexts. Several spirometric findings outside of a reduced forced expiratory volume in one second/forced vital capacity ratio should raise suspicion of mild obstruction.

审查目的:肺活量测定法是诊断阻塞性气道疾病的有效工具。然而,它在检测小气道气流受限方面可能不够敏感。本综述强调了气流受限可能被遗漏或忽视的常见临床情况:本文涵盖了有关肺功能测试解读的最新文献,重点关注轻度阻塞性气道疾病的检测。摘要:我们强调了轻度阻塞性气道疾病的共识定义,并强调这一定义在某些特定疾病情况下并不一定意味着轻度。除了一秒钟用力呼气量/用力生命容量比值降低外,一些肺活量测定结果也应引起对轻度阻塞的怀疑。
{"title":"Mild airways obstruction: spirometric diagnostic pitfalls and solutions.","authors":"Nawaf M Alotaibi, Rachel L Eddy, Don D Sin","doi":"10.1097/MCP.0000000000001023","DOIUrl":"10.1097/MCP.0000000000001023","url":null,"abstract":"<p><strong>Purpose of review: </strong>Spirometry is a validated tool in the diagnosis of obstructive airways disease. However, it may be insufficiently sensitive in detecting airflow limitation in the small airways. This review highlights common clinical scenarios wherein airflow limitation may be missed or overlooked.</p><p><strong>Recent findings: </strong>This article covers recent literature on the interpretation of lung function test, focusing on detection of mild obstructive airways disease. It also sheds light on the contextual difficulties of defining mild airflow limitation on spirometry.</p><p><strong>Summary: </strong>We highlight the consensus definition of mild obstructive airways disease and emphasize that this definition does not necessarily mean mild in certain disease-specific contexts. Several spirometric findings outside of a reduced forced expiratory volume in one second/forced vital capacity ratio should raise suspicion of mild obstruction.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139540977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence for the optimal management of community-acquired pneumonia. 人工智能对社区获得性肺炎的优化管理。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-02-03 DOI: 10.1097/mcp.0000000000001055
Maria Antonietta Barbieri, Vera Battini, Sessa Maurizio
This timely review explores the integration of artificial intelligence (AI) into community-acquired pneumonia (CAP) management, emphasizing its relevance in predicting the risk of hospitalization. With CAP remaining a global public health concern, the review highlights the need for efficient and reliable AI tools to optimize resource allocation and improve patient outcomes.
这篇及时的综述探讨了将人工智能(AI)融入社区获得性肺炎(CAP)管理的问题,强调了人工智能在预测住院风险方面的相关性。由于 CAP 仍是一个全球性的公共卫生问题,这篇综述强调了对高效可靠的人工智能工具的需求,以优化资源分配和改善患者预后。
{"title":"Artificial intelligence for the optimal management of community-acquired pneumonia.","authors":"Maria Antonietta Barbieri, Vera Battini, Sessa Maurizio","doi":"10.1097/mcp.0000000000001055","DOIUrl":"https://doi.org/10.1097/mcp.0000000000001055","url":null,"abstract":"This timely review explores the integration of artificial intelligence (AI) into community-acquired pneumonia (CAP) management, emphasizing its relevance in predicting the risk of hospitalization. With CAP remaining a global public health concern, the review highlights the need for efficient and reliable AI tools to optimize resource allocation and improve patient outcomes.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139664782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The diagnosis and management of chronic lung allograft dysfunction. 慢性肺移植功能障碍的诊断和管理。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-02-03 DOI: 10.1097/mcp.0000000000001053
Geert M Verleden, Jeroen M H Hendriks, Stijn E Verleden
Chronic lung allograft dysfunction (CLAD) remains a life-threatening complication following lung transplantation. Different CLAD phenotypes have recently been defined, based on the combination of pulmonary function testing and chest computed tomography (CT) scanning and spurred renewed interests in differential diagnosis, risk factors and management of CLAD.
慢性肺移植功能障碍(CLAD)仍然是肺移植后危及生命的并发症。最近,根据肺功能测试和胸部计算机断层扫描(CT)相结合的方法,对不同的 CLAD 表型进行了定义,这重新激发了人们对 CLAD 的鉴别诊断、风险因素和管理的兴趣。
{"title":"The diagnosis and management of chronic lung allograft dysfunction.","authors":"Geert M Verleden, Jeroen M H Hendriks, Stijn E Verleden","doi":"10.1097/mcp.0000000000001053","DOIUrl":"https://doi.org/10.1097/mcp.0000000000001053","url":null,"abstract":"Chronic lung allograft dysfunction (CLAD) remains a life-threatening complication following lung transplantation. Different CLAD phenotypes have recently been defined, based on the combination of pulmonary function testing and chest computed tomography (CT) scanning and spurred renewed interests in differential diagnosis, risk factors and management of CLAD.","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139664649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is new in mediastinal staging? 纵隔分期有什么新进展?
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-10-26 DOI: 10.1097/MCP.0000000000001022
Audra J Schwalk, Abesh Niroula, Matthew Schimmel

Purpose of review: Appropriate staging is of utmost importance in nonsmall cell lung cancer (NSCLC), as the pathologic stage dictates both overall prognosis and appropriate therapeutic pathways. This article seeks to review the current recommendations for mediastinal staging of NSCLC and available modalities to achieve this. Landmark publications pertaining to recent advancements in NSCLC treatments are also highlighted and the role of specific bronchoscopic modalities for tissue acquisition are reviewed.

Recent findings: Recent advancements in the treatment of NSCLC have made accurate mediastinal staging more important than ever. Guidelines and recommendations outlining patients that warrant invasive mediastinal staging are available and a systematic approach should be utilized when sampling is performed. Ensuring the adequacy of tissue for the growing number of molecular biomarkers that must be tested has been the focus of many recent studies.

Summary: Appropriate mediastinal staging is crucial for the management of patients with NSCLC as is obtaining adequate tissue for diagnostic and therapeutic purposes. EBUS-TBNA is sufficient for the diagnosis of nonsmall cell and small cell lung carcinomas, but EBUS-guided intranodal forceps and cryobiopsy may provide more optimal specimen for patients with benign disease, such as sarcoidosis, or in cases of lymphoma. Further studies are necessary to better delineate the role of these techniques in the diagnosis and staging of mediastinal diseases before they become the primary diagnostic modalities.

综述目的:在非小细胞肺癌癌症(NSCLC)中,适当的分期至关重要,因为病理分期决定了总体预后和适当的治疗途径。本文旨在回顾目前对非小细胞肺癌纵隔分期的建议以及实现这一目标的可用方法。还强调了与NSCLC治疗的最新进展有关的标志性出版物,并回顾了特定支气管镜模式在组织获取中的作用。最近的发现:NSCLC治疗的最新进展使准确的纵隔分期比以往任何时候都更重要。概述患者有必要进行侵袭性纵隔分期的指南和建议是可用的,在进行采样时应采用系统方法。确保组织对越来越多必须测试的分子生物标志物的充分性一直是最近许多研究的重点。总结:适当的纵隔分期对于NSCLC患者的管理至关重要,因为获得足够的组织用于诊断和治疗目的也是如此。EBUS-TBNA足以诊断非小细胞和小细胞肺癌,但EBUS引导的结内钳和冷冻活检可以为良性疾病(如结节病)或淋巴瘤患者提供更理想的标本。在纵隔疾病成为主要诊断模式之前,有必要进行进一步的研究,以更好地描述这些技术在纵隔疾病诊断和分期中的作用。
{"title":"What is new in mediastinal staging?","authors":"Audra J Schwalk, Abesh Niroula, Matthew Schimmel","doi":"10.1097/MCP.0000000000001022","DOIUrl":"10.1097/MCP.0000000000001022","url":null,"abstract":"<p><strong>Purpose of review: </strong>Appropriate staging is of utmost importance in nonsmall cell lung cancer (NSCLC), as the pathologic stage dictates both overall prognosis and appropriate therapeutic pathways. This article seeks to review the current recommendations for mediastinal staging of NSCLC and available modalities to achieve this. Landmark publications pertaining to recent advancements in NSCLC treatments are also highlighted and the role of specific bronchoscopic modalities for tissue acquisition are reviewed.</p><p><strong>Recent findings: </strong>Recent advancements in the treatment of NSCLC have made accurate mediastinal staging more important than ever. Guidelines and recommendations outlining patients that warrant invasive mediastinal staging are available and a systematic approach should be utilized when sampling is performed. Ensuring the adequacy of tissue for the growing number of molecular biomarkers that must be tested has been the focus of many recent studies.</p><p><strong>Summary: </strong>Appropriate mediastinal staging is crucial for the management of patients with NSCLC as is obtaining adequate tissue for diagnostic and therapeutic purposes. EBUS-TBNA is sufficient for the diagnosis of nonsmall cell and small cell lung carcinomas, but EBUS-guided intranodal forceps and cryobiopsy may provide more optimal specimen for patients with benign disease, such as sarcoidosis, or in cases of lymphoma. Further studies are necessary to better delineate the role of these techniques in the diagnosis and staging of mediastinal diseases before they become the primary diagnostic modalities.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41233182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging in peripheral bronchoscopy. 外周支气管镜成像。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-07 DOI: 10.1097/MCP.0000000000001028
Brian D Shaller, Sonali Sethi, Joseph Cicenia

Purpose of review: Historically the sampling of peripheral lung lesions via bronchoscopy has suffered from inferior diagnostic outcomes relative to transthoracic needle aspiration, and neither a successful bronchoscopic navigation nor a promising radial ultrasonographic image of one's target lesion guarantees a successful biopsy. Fortunately, many of peripheral bronchoscopy's shortcomings - including an inability to detect and compensate for computed tomography (CT)-body divergence, and the absence of tool-in-lesion confirmation - are potentially remediable through the use of improved intraprocedural imaging techniques.

Recent findings: Recent advances in intraprocedural imaging, including the integration of cone beam CT, digital tomosynthesis, and augmented fluoroscopy into bronchoscopic procedures have yielded promising results. These advanced imaging modalities may improve the outcomes of peripheral bronchoscopy through the detection and correction of navigational errors, CT-body divergence, and malpositioned biopsy instruments.

Summary: The incorporation of advanced imaging is an essential step in the improvement of peripheral bronchoscopic procedures.

综述目的:从历史上看,与经胸穿刺相比,通过支气管镜对周围肺部病变进行采样的诊断结果较差,无论是成功的支气管镜导航还是有希望的目标病变的径向超声图像都不能保证活检成功。幸运的是,外周支气管镜检查的许多缺点——包括无法检测和补偿计算机断层扫描(CT)、身体发散以及缺乏病变确认工具——都可以通过使用改进的术中成像技术来弥补。最新发现:术中成像的最新进展,包括锥束CT、数字断层合成和增强荧光镜检查在支气管镜检查中的集成,已经产生了有希望的结果。这些先进的成像模式可以通过检测和纠正导航错误、CT身体发散和活检仪器错位来改善外周支气管镜检查的结果。摘要:结合先进的影像学是改善外周支气管镜检查程序的重要步骤。
{"title":"Imaging in peripheral bronchoscopy.","authors":"Brian D Shaller, Sonali Sethi, Joseph Cicenia","doi":"10.1097/MCP.0000000000001028","DOIUrl":"10.1097/MCP.0000000000001028","url":null,"abstract":"<p><strong>Purpose of review: </strong>Historically the sampling of peripheral lung lesions via bronchoscopy has suffered from inferior diagnostic outcomes relative to transthoracic needle aspiration, and neither a successful bronchoscopic navigation nor a promising radial ultrasonographic image of one's target lesion guarantees a successful biopsy. Fortunately, many of peripheral bronchoscopy's shortcomings - including an inability to detect and compensate for computed tomography (CT)-body divergence, and the absence of tool-in-lesion confirmation - are potentially remediable through the use of improved intraprocedural imaging techniques.</p><p><strong>Recent findings: </strong>Recent advances in intraprocedural imaging, including the integration of cone beam CT, digital tomosynthesis, and augmented fluoroscopy into bronchoscopic procedures have yielded promising results. These advanced imaging modalities may improve the outcomes of peripheral bronchoscopy through the detection and correction of navigational errors, CT-body divergence, and malpositioned biopsy instruments.</p><p><strong>Summary: </strong>The incorporation of advanced imaging is an essential step in the improvement of peripheral bronchoscopic procedures.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71479188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchoscopic lung volume reduction in emphysema: a review. 肺气肿的支气管镜肺减容术:综述。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-02 DOI: 10.1097/MCP.0000000000001031
Nakul Ravikumar, Ajay Wagh, Van K Holden, D Kyle Hogarth

Purpose of review: Chronic obstructive pulmonary disease (COPD) poses a substantial burden on the healthcare system and is currently considered the sixth leading cause of death in the United States. Emphysema, as evidenced by severe air-trapping in patients with COPD, leads to significant dyspnea and morbidity. Lung volume reduction via surgery or minimally invasive endobronchial interventions are currently available, which improve lung function and quality of life.

Recent findings: Newer studies have noted a survival benefit in patients post bronchoscopic lung volume reduction vs. those subjected to standard of care. The presence of collateral ventilation is one of the most common impeding factors to placing endobronchial valves, and if placed, these patients might not achieve lobar atelectasis; however, there are newer modalities that are now available for patients with collateral ventilation which we have described.

Summary: Combining standard of care treatment that includes smoking cessation, bronchodilators, preventive care including vaccinations, pulmonary rehabilitation, and endobronchial treatment using various interventions in decreasing hyperinflation improves quality of life and may improve survival and hence significantly reduce the burden of COPD on healthcare.

综述目的:慢性阻塞性肺病(COPD)对医疗系统构成了巨大负担,目前被认为是美国第六大死亡原因。慢性阻塞性肺病患者的肺气肿表现为严重的空气滞留,会导致严重的呼吸困难和发病率。目前可以通过手术或微创支气管内干预来减少肺容量,从而改善肺功能和生活质量。最近的发现:较新的研究表明,与接受标准护理的患者相比,支气管镜检查后肺容量减少的患者有生存益处。侧支通气是放置支气管内瓣膜最常见的阻碍因素之一,如果放置,这些患者可能不会出现肺叶肺不张;然而,我们已经描述过,现在有一些新的模式可用于辅助通气患者。总结:将包括戒烟、支气管扩张剂在内的标准护理治疗、包括疫苗接种在内的预防性护理、肺部康复和支气管内治疗相结合,使用各种干预措施来减少恶性通货膨胀,可以提高生活质量,并可提高生存率,从而显著减轻COPD对医疗保健的负担。
{"title":"Bronchoscopic lung volume reduction in emphysema: a review.","authors":"Nakul Ravikumar, Ajay Wagh, Van K Holden, D Kyle Hogarth","doi":"10.1097/MCP.0000000000001031","DOIUrl":"10.1097/MCP.0000000000001031","url":null,"abstract":"<p><strong>Purpose of review: </strong>Chronic obstructive pulmonary disease (COPD) poses a substantial burden on the healthcare system and is currently considered the sixth leading cause of death in the United States. Emphysema, as evidenced by severe air-trapping in patients with COPD, leads to significant dyspnea and morbidity. Lung volume reduction via surgery or minimally invasive endobronchial interventions are currently available, which improve lung function and quality of life.</p><p><strong>Recent findings: </strong>Newer studies have noted a survival benefit in patients post bronchoscopic lung volume reduction vs. those subjected to standard of care. The presence of collateral ventilation is one of the most common impeding factors to placing endobronchial valves, and if placed, these patients might not achieve lobar atelectasis; however, there are newer modalities that are now available for patients with collateral ventilation which we have described.</p><p><strong>Summary: </strong>Combining standard of care treatment that includes smoking cessation, bronchodilators, preventive care including vaccinations, pulmonary rehabilitation, and endobronchial treatment using various interventions in decreasing hyperinflation improves quality of life and may improve survival and hence significantly reduce the burden of COPD on healthcare.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical thoracoscopy for pleural diseases. 胸膜疾病的医用胸腔镜。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-14 DOI: 10.1097/MCP.0000000000001039
Matsuo So, Udit Chaddha, Samira Shojaee, Pyng Lee

Purpose of review: The purpose of this review is to elaborate on the role of medical thoracoscopy for various diagnostic and therapeutic parietal pleural interventions. The renewed interest in medical thoracoscopy has been boosted by the growth of the field of interventional pulmonology and, possibly, well tolerated and evolving anesthesia.

Recent findings: Medical thoracoscopy to obtain pleural biopsies is established largely as a safe and effective diagnostic procedure. Recent data suggest how a pragmatic biopsy-first approach in specific cancer scenarios may be patient-centered. The current scope of medical thoracoscopy for therapeutic interventions other than pleurodesis and indwelling pleural catheter (IPC) placement is limited. In this review, we discuss the available evidence for therapeutic indications and why we must tread with caution in certain scenarios.

Summary: This article reviews contemporary published data to highlight the best utility of medical thoracoscopy as a diagnostic procedure for undiagnosed exudative effusions or effusions suspected to be secondary to cancers or tuberculosis. The potentially therapeutic role of medical thoracoscopy in patients with pneumothorax or empyema warrants further research focusing on patient-centered outcomes and comparisons with video-assisted thoracoscopic surgery.

综述目的:本综述的目的是详细阐述医学胸腔镜在各种胸膜壁干预诊断和治疗中的作用。介入肺脏学领域的发展,以及可能的良好耐受和不断发展的麻醉,推动了对医学胸腔镜的重新兴趣。医学胸腔镜获得胸膜活检在很大程度上是一种安全有效的诊断方法。最近的数据表明,在特定的癌症情况下,务实的活检优先方法可能以患者为中心。目前医学胸腔镜在胸膜穿刺和留置胸膜导管(IPC)以外的治疗干预中的应用范围是有限的。在这篇综述中,我们讨论了治疗适应症的现有证据,以及为什么在某些情况下我们必须谨慎行事。摘要:本文回顾了当代发表的数据,以强调医学胸腔镜作为诊断未确诊的渗出性积液或疑似继发于癌症或结核病的积液的最佳应用。内科胸腔镜在气胸或脓胸患者中的潜在治疗作用值得进一步研究,重点关注以患者为中心的结果,并与视频辅助胸腔镜手术进行比较。
{"title":"Medical thoracoscopy for pleural diseases.","authors":"Matsuo So, Udit Chaddha, Samira Shojaee, Pyng Lee","doi":"10.1097/MCP.0000000000001039","DOIUrl":"10.1097/MCP.0000000000001039","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to elaborate on the role of medical thoracoscopy for various diagnostic and therapeutic parietal pleural interventions. The renewed interest in medical thoracoscopy has been boosted by the growth of the field of interventional pulmonology and, possibly, well tolerated and evolving anesthesia.</p><p><strong>Recent findings: </strong>Medical thoracoscopy to obtain pleural biopsies is established largely as a safe and effective diagnostic procedure. Recent data suggest how a pragmatic biopsy-first approach in specific cancer scenarios may be patient-centered. The current scope of medical thoracoscopy for therapeutic interventions other than pleurodesis and indwelling pleural catheter (IPC) placement is limited. In this review, we discuss the available evidence for therapeutic indications and why we must tread with caution in certain scenarios.</p><p><strong>Summary: </strong>This article reviews contemporary published data to highlight the best utility of medical thoracoscopy as a diagnostic procedure for undiagnosed exudative effusions or effusions suspected to be secondary to cancers or tuberculosis. The potentially therapeutic role of medical thoracoscopy in patients with pneumothorax or empyema warrants further research focusing on patient-centered outcomes and comparisons with video-assisted thoracoscopic surgery.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92153147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anesthetic considerations in interventional pulmonology. 介入肺科的麻醉注意事项。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-06 DOI: 10.1097/MCP.0000000000001033
Rutuja R Sikachi, Kelly Louise Mishra, Megan Anders

Purpose of review: In this review, we highlight the important anesthetic consideration that relate to interventional bronchoscopic procedures for the management of central airway obstruction due to anterior mediastinal masses, endoluminal endobronchial obstruction, peripheral bronchoscopy for diagnosis and treatment of lung nodules, bronchoscopic lung volume reduction and medical pleuroscopy for diagnosis and management of pleural diseases.

Recent findings: The advent of the field of Interventional Pulmonology has allowed for minimally invasive options for patients with a wide range of lung diseases which at times have replaced more invasive surgical procedures. Ongoing research has shed light on advancement in anesthetic techniques and management strategies that have increased the safety during peri-operative management during these complex procedures. Current evidence focusing on the anesthetic techniques is presented here.

Summary: The field of Interventional Pulmonology requires a tailored anesthetic approach. Recent advancements and ongoing research have focused on expanding the partnership between the anesthesiologist and interventional pulmonologists which has led to improved outcomes for patients undergoing these procedures.

综述目的:在这篇综述中,我们强调了与介入支气管镜手术相关的重要麻醉考虑因素,用于治疗前纵隔肿块引起的中央气道阻塞、管腔内支气管阻塞、外周支气管镜检查用于诊断和治疗肺结节,支气管镜肺减容和医用胸膜镜检查用于胸膜疾病的诊断和治疗。最近的发现:介入性肺病领域的出现为患有各种肺部疾病的患者提供了微创选择,这些疾病有时已经取代了更具侵入性的外科手术。正在进行的研究揭示了麻醉技术和管理策略的进步,这些技术和策略提高了这些复杂手术的围手术期管理的安全性。目前的证据集中在麻醉技术在这里提出。摘要:介入性肺病领域需要量身定制的麻醉方法。最近的进展和正在进行的研究集中在扩大麻醉师和介入肺科医生之间的合作关系上,这改善了接受这些手术的患者的预后。
{"title":"Anesthetic considerations in interventional pulmonology.","authors":"Rutuja R Sikachi, Kelly Louise Mishra, Megan Anders","doi":"10.1097/MCP.0000000000001033","DOIUrl":"10.1097/MCP.0000000000001033","url":null,"abstract":"<p><strong>Purpose of review: </strong>In this review, we highlight the important anesthetic consideration that relate to interventional bronchoscopic procedures for the management of central airway obstruction due to anterior mediastinal masses, endoluminal endobronchial obstruction, peripheral bronchoscopy for diagnosis and treatment of lung nodules, bronchoscopic lung volume reduction and medical pleuroscopy for diagnosis and management of pleural diseases.</p><p><strong>Recent findings: </strong>The advent of the field of Interventional Pulmonology has allowed for minimally invasive options for patients with a wide range of lung diseases which at times have replaced more invasive surgical procedures. Ongoing research has shed light on advancement in anesthetic techniques and management strategies that have increased the safety during peri-operative management during these complex procedures. Current evidence focusing on the anesthetic techniques is presented here.</p><p><strong>Summary: </strong>The field of Interventional Pulmonology requires a tailored anesthetic approach. Recent advancements and ongoing research have focused on expanding the partnership between the anesthesiologist and interventional pulmonologists which has led to improved outcomes for patients undergoing these procedures.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71479187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in interventional pulmonology. 人工智能在介入肺科。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-02 DOI: 10.1097/MCP.0000000000001024
Tsukasa Ishiwata, Kazuhiro Yasufuku

Purpose of review: In recent years, there has been remarkable progress in the field of artificial intelligence technology. Artificial intelligence applications have been extensively researched and actively implemented across various domains within healthcare. This study reviews the current state of artificial intelligence research in interventional pulmonology and engages in a discussion to comprehend its capabilities and implications.

Recent findings: Deep learning, a subset of artificial intelligence, has found extensive applications in recent years, enabling highly accurate identification and labeling of bronchial segments solely from intraluminal bronchial images. Furthermore, research has explored the use of artificial intelligence for the analysis of endobronchial ultrasound images, achieving a high degree of accuracy in distinguishing between benign and malignant targets within ultrasound images. These advancements have become possible due to the increased computational power of modern systems and the utilization of vast datasets, facilitating detections and predictions with greater precision and speed.

Summary: Artificial intelligence integration into interventional pulmonology has the potential to enhance diagnostic accuracy and patient safety, ultimately leading to improved patient outcomes. However, the clinical impacts of artificial intelligence enhanced procedures remain unassessed. Additional research is necessary to evaluate both the advantages and disadvantages of artificial intelligence in the field of interventional pulmonology.

综述目的:近年来,人工智能技术领域取得了显著进展。人工智能应用已在医疗保健的各个领域得到广泛研究和积极实施。本研究回顾了人工智能在介入肺科的研究现状,并进行了讨论,以了解其能力和意义。最近的发现:深度学习是人工智能的一个子集,近年来得到了广泛的应用,能够仅从管腔内支气管图像中高度准确地识别和标记支气管段。此外,研究探索了使用人工智能分析支气管内超声图像,在区分超声图像中的良性和恶性目标方面实现了高度准确。由于现代系统计算能力的提高和大量数据集的利用,这些进步成为可能,有助于以更高的精度和速度进行检测和预测。摘要:人工智能与介入肺科的结合有可能提高诊断准确性和患者安全性,最终改善患者的预后。然而,人工智能增强程序的临床影响仍然没有得到评估。有必要进行更多的研究,以评估人工智能在介入肺科领域的优势和劣势。
{"title":"Artificial intelligence in interventional pulmonology.","authors":"Tsukasa Ishiwata, Kazuhiro Yasufuku","doi":"10.1097/MCP.0000000000001024","DOIUrl":"10.1097/MCP.0000000000001024","url":null,"abstract":"<p><strong>Purpose of review: </strong>In recent years, there has been remarkable progress in the field of artificial intelligence technology. Artificial intelligence applications have been extensively researched and actively implemented across various domains within healthcare. This study reviews the current state of artificial intelligence research in interventional pulmonology and engages in a discussion to comprehend its capabilities and implications.</p><p><strong>Recent findings: </strong>Deep learning, a subset of artificial intelligence, has found extensive applications in recent years, enabling highly accurate identification and labeling of bronchial segments solely from intraluminal bronchial images. Furthermore, research has explored the use of artificial intelligence for the analysis of endobronchial ultrasound images, achieving a high degree of accuracy in distinguishing between benign and malignant targets within ultrasound images. These advancements have become possible due to the increased computational power of modern systems and the utilization of vast datasets, facilitating detections and predictions with greater precision and speed.</p><p><strong>Summary: </strong>Artificial intelligence integration into interventional pulmonology has the potential to enhance diagnostic accuracy and patient safety, ultimately leading to improved patient outcomes. However, the clinical impacts of artificial intelligence enhanced procedures remain unassessed. Additional research is necessary to evaluate both the advantages and disadvantages of artificial intelligence in the field of interventional pulmonology.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchoscopic interventions for chronic bronchitis. 慢性支气管炎的支气管镜介入治疗。
IF 3.3 3区 医学 Q2 Medicine Pub Date : 2024-01-01 Epub Date: 2023-11-09 DOI: 10.1097/MCP.0000000000001036
Anand Tana, Chenchen Zhang, David DiBardino, Christopher M Orton, Pallav L Shah

Purpose of review: Chronic bronchitis is a phenotype of chronic obstructive pulmonary disease (COPD), characterized by chronic cough and sputum production, associated with an increased rate of COPD exacerbations and hospital admissions, a more rapid decline in lung function and reduced life expectancy. Despite optimal medical therapy, chronic bronchitis remains difficult to treat. Interventional bronchoscopic procedures offer novel therapeutic approaches to this highly symptomatic condition.

Recent findings: A characteristic feature of chronic bronchitis is the presence of an abnormal epithelium with excessive mucus producing cells, parasympathetic overactivity, and airway inflammation. Metered cryospray and bronchial rheoplasty are designed to target this abnormal epithelium to reduce mucus production and inflammation. Targeted lung denervation aims to reduce parasympathetic overactivity, which may drive mucus hypersecretion. Here, we review the available evidence to determine the safety and efficacy across the bronchoscopic interventions.

Summary: Interventional bronchoscopy is a rapidly expanding field and its application in the treatment of chronic bronchitis has been recognized by the Global initiative for chronic Obstructive Lung Disease (GOLD). The outcomes from the latest clinical trials will guide future treatment approaches in patients with difficult to treat chronic bronchitis.

综述目的:慢性支气管炎是慢性阻塞性肺病(COPD)的一种表型,其特征是慢性咳嗽和痰液生成,与COPD恶化率和住院率增加、肺功能更快下降和预期寿命缩短有关。尽管有最佳的药物治疗,慢性支气管炎仍然难以治疗。介入性支气管镜检查为这种高度症状性疾病提供了新的治疗方法。最近的研究结果:慢性支气管炎的一个特征是存在异常上皮,具有过多的粘液产生细胞、副交感神经过度活动和气道炎症。Metered冷冻喷雾和支气管流变成形术旨在针对这种异常上皮,减少粘液的产生和炎症。有针对性的肺去神经支配旨在减少副交感神经的过度活动,这可能会导致粘液分泌过多。在这里,我们回顾了现有的证据,以确定支气管镜干预的安全性和有效性。摘要:介入支气管镜检查是一个快速发展的领域,其在治疗慢性支气管炎方面的应用已得到全球慢性阻塞性肺病倡议(GOLD)的认可。最新临床试验的结果将指导未来难以治疗的慢性支气管炎患者的治疗方法。
{"title":"Bronchoscopic interventions for chronic bronchitis.","authors":"Anand Tana, Chenchen Zhang, David DiBardino, Christopher M Orton, Pallav L Shah","doi":"10.1097/MCP.0000000000001036","DOIUrl":"10.1097/MCP.0000000000001036","url":null,"abstract":"<p><strong>Purpose of review: </strong>Chronic bronchitis is a phenotype of chronic obstructive pulmonary disease (COPD), characterized by chronic cough and sputum production, associated with an increased rate of COPD exacerbations and hospital admissions, a more rapid decline in lung function and reduced life expectancy. Despite optimal medical therapy, chronic bronchitis remains difficult to treat. Interventional bronchoscopic procedures offer novel therapeutic approaches to this highly symptomatic condition.</p><p><strong>Recent findings: </strong>A characteristic feature of chronic bronchitis is the presence of an abnormal epithelium with excessive mucus producing cells, parasympathetic overactivity, and airway inflammation. Metered cryospray and bronchial rheoplasty are designed to target this abnormal epithelium to reduce mucus production and inflammation. Targeted lung denervation aims to reduce parasympathetic overactivity, which may drive mucus hypersecretion. Here, we review the available evidence to determine the safety and efficacy across the bronchoscopic interventions.</p><p><strong>Summary: </strong>Interventional bronchoscopy is a rapidly expanding field and its application in the treatment of chronic bronchitis has been recognized by the Global initiative for chronic Obstructive Lung Disease (GOLD). The outcomes from the latest clinical trials will guide future treatment approaches in patients with difficult to treat chronic bronchitis.</p>","PeriodicalId":11090,"journal":{"name":"Current Opinion in Pulmonary Medicine","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71520783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Pulmonary Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1